Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2012 Feb 01;1654:880-96. doi: 10.1111/j.1476-5381.2011.01604.x.
Show Gene links
Show Anatomy links
2'-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors.
Karim N, Curmi J, Gavande N, Johnston GA, Hanrahan JR, Tierney ML, Chebib M.
???displayArticle.abstract???
Flavonoids are known to have anxiolytic and sedative effects mediated via actions on ionotropic GABA receptors. We sought to investigate this further.We evaluated the effects of 2'-methoxy-6-methylflavone (2'MeO6MF) on native GABA(A) receptors in new-born rat hippocampal neurons and determined specificity from 18 human recombinant GABA(A) receptor subtypes expressed in Xenopus oocytes. We used ligand binding, two-electrode voltage clamp and patch clamp studies together with behavioural studies.2'MeO6MF potentiated GABA at α2β1γ2L and all α1-containing GABA(A) receptor subtypes. At α2β2/3γ2L GABA(A) receptors, however, 2'MeO6MF directly activated the receptors without potentiating GABA. This activation was attenuated by bicuculline and gabazine but not flumazenil indicating a novel site. Mutation studies showed position 265 in the β1/2 subunit was key to whether 2'MeO6MF was an activator or a potentiator. In hippocampal neurons, 2'MeO6MF directly activated single-channel currents that showed the hallmarks of GABA(A) Cl(-) currents. In the continued presence of 2'MeO6MF the single-channel conductance increased and these high conductance channels were disrupted by the γ2(381-403) MA peptide, indicating that such currents are mediated by α2/γ2-containing GABA(A) receptors. In mice, 2'MeO6MF (1-100 mg·kg(-1) ; i.p.) displayed anxiolytic-like effects in two unconditioned models of anxiety: the elevated plus maze and light/dark tests. 2'MeO6MF induced sedative effects at higher doses in the holeboard, actimeter and barbiturate-induced sleep time tests. No myorelaxant effects were observed in the horizontal wire test.2'MeO6MF will serve as a tool to study the complex nature of the activation and modulation of GABA(A) receptor subtypes.
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011, Pubmed
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011,
Pubmed Atack,
GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
2011,
Pubmed Atack,
GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
2011,
Pubmed Atack,
The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics.
2005,
Pubmed Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase Boileau,
The relative amount of cRNA coding for gamma2 subunits affects stimulation by benzodiazepines in GABA(A) receptors expressed in Xenopus oocytes.
2002,
Pubmed
,
Xenbase Bonetti,
Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.
1982,
Pubmed Bourin,
The mouse light/dark box test.
2003,
Pubmed Caraiscos,
Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane.
2004,
Pubmed Chebib,
Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory.
2009,
Pubmed
,
Xenbase Crestani,
Molecular targets for the myorelaxant action of diazepam.
2001,
Pubmed Crestani,
Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.
2002,
Pubmed Curmi,
The influence of membrane potential on chloride channels activated by GABA in rat cultured hippocampal neurons.
1993,
Pubmed Desai,
Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
2009,
Pubmed
,
Xenbase Eghbali,
Hippocampal GABA(A) channel conductance increased by diazepam.
1997,
Pubmed Eghbali,
Effects of propofol on GABAA channel conductance in rat-cultured hippocampal neurons.
2003,
Pubmed Everitt,
Protein interactions involving the gamma2 large cytoplasmic loop of GABA(A) receptors modulate conductance.
2009,
Pubmed Farrant,
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.
2005,
Pubmed Fernandez,
Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
2008,
Pubmed
,
Xenbase Ferrini,
Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.
1974,
Pubmed File,
The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
1985,
Pubmed Gamet-Payrastre,
Flavonoids and the inhibition of PKC and PI 3-kinase.
1999,
Pubmed Gee,
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.
2010,
Pubmed
,
Xenbase Groves,
The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.
2006,
Pubmed Hall,
6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes.
2005,
Pubmed
,
Xenbase Hall,
Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptors.
2004,
Pubmed
,
Xenbase Halliwell,
Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid.
1999,
Pubmed
,
Xenbase Hanrahan,
Flavonoid modulation of GABA(A) receptors.
2011,
Pubmed Herd,
The expression of GABAA beta subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells.
2008,
Pubmed Hill-Venning,
Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor.
1997,
Pubmed
,
Xenbase Hodge,
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon.
2002,
Pubmed Hosie,
Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.
2003,
Pubmed Huang,
Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action.
2001,
Pubmed
,
Xenbase Irwin,
Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse.
1968,
Pubmed Jäger,
Flavonoids and the CNS.
2011,
Pubmed Jiang,
Retrochalcone derivatives are positive allosteric modulators at synaptic and extrasynaptic GABA(A) receptors in vitro.
2011,
Pubmed Kahnberg,
Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor.
2002,
Pubmed Lambert,
Neurosteroid modulation of native and recombinant GABAA receptors.
1996,
Pubmed Lippa,
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
2005,
Pubmed
,
Xenbase Löw,
Molecular and neuronal substrate for the selective attenuation of anxiety.
2000,
Pubmed Maitra,
Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.
1998,
Pubmed
,
Xenbase Mangan,
Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors.
2005,
Pubmed Mattila,
Determination of flavonoids in plant material by HPLC with diode-array and electro-array detections.
2000,
Pubmed McKernan,
Which GABAA-receptor subtypes really occur in the brain?
1996,
Pubmed Mihalek,
Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.
1999,
Pubmed Nilsson,
Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site.
2011,
Pubmed Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed Orser,
Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons.
1994,
Pubmed Popik,
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
2006,
Pubmed
,
Xenbase Ransom,
Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines.
1988,
Pubmed Ren,
GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone.
2010,
Pubmed Rudolph,
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
1999,
Pubmed Seymour,
Differential drug responses on native GABA(A) receptors revealing heterogeneity in extrasynaptic populations in cultured hippocampal neurons.
2009,
Pubmed Sieghart,
Structure, pharmacology, and function of GABAA receptor subtypes.
2006,
Pubmed Thompson,
Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
1996,
Pubmed
,
Xenbase Tierney,
Insights into the biophysical properties of GABA(A) ion channels: modulation of ion permeation by drugs and protein interactions.
2011,
Pubmed Wang,
6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
2007,
Pubmed Whiting,
GABA-A receptors: a viable target for novel anxiolytics?
2006,
Pubmed
